These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33616873)

  • 1. Recombinant L-HN Fusion Antigen Derived from the L and HN Domains of Botulinum Neurotoxin B Stimulates a Protective Antibody Response Against Active Neurotoxin.
    Li Z; Lu JS; Liu S; Wang R; Xu Q; Yu YZ; Yang ZX
    Neurotox Res; 2021 Aug; 39(4):1044-1053. PubMed ID: 33616873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A.
    Liu FJ; Shi DY; Mao YY; Xiong XH; Lu JS; Pang XB; Dong XJ; Yang ZX; Yu YZ
    Vaccine; 2020 Mar; 38(14):2978-2983. PubMed ID: 32113807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
    Yu Y; Shi D; Liu S; Gong ZW; Wang S; Sun Z
    Hum Vaccin Immunother; 2015; 11(2):468-73. PubMed ID: 25483668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B.
    Shi DY; Chen BY; Mao YY; Zhou G; Lu JS; Yu YZ; Zhou XW; Sun ZW
    Hum Vaccin Immunother; 2019; 15(3):755-760. PubMed ID: 30433836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E.
    Li Z; Lu J; Tan X; Wang R; Xu Q; Yu Y; Yang Z
    Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202162
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E.
    Liu Y; Liu X; Chen W; Yu Y; Meng J; Wang J
    Front Immunol; 2024; 15():1469919. PubMed ID: 39315101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and Immunological Characterization of a Functional L-HN Derivative of Botulinum Neurotoxin Serotype F.
    Li Z; Li B; Lu J; Liu X; Tan X; Wang R; Du P; Yu S; Xu Q; Pang X; Yu Y; Yang Z
    Toxins (Basel); 2023 Mar; 15(3):. PubMed ID: 36977091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin.
    Ayyar BV; Tajhya RB; Beeton C; Atassi MZ
    Sci Rep; 2015 Oct; 5():15776. PubMed ID: 26508475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen.
    Gao YL; Gao S; Kang L; Nie C; Wang JL
    Hum Vaccin; 2010 Jun; 6(6):462-6. PubMed ID: 20519939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing toxin-based vaccines against botulism.
    Przedpelski A; Tepp WH; Zuverink M; Johnson EA; Pellet S; Barbieri JT
    Vaccine; 2018 Feb; 36(6):827-832. PubMed ID: 29307477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
    Baldwin MR; Tepp WH; Pier CL; Bradshaw M; Ho M; Wilson BA; Fritz RB; Johnson EA; Barbieri JT
    Infect Immun; 2005 Oct; 73(10):6998-7005. PubMed ID: 16177380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B).
    Shearer JD; Vassar ML; Swiderski W; Metcalfe K; Niemuth N; Henderson I
    Vaccine; 2010 Oct; 28(45):7313-8. PubMed ID: 20816903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetanus toxin and botulinum neurotoxin-derived fusion molecules are effective bivalent vaccines.
    Li BL; Wang JR; Liu XY; Lu JS; Wang R; Du P; Yu S; Pang XB; Yu YZ; Yang ZX
    Appl Microbiol Biotechnol; 2023 Dec; 107(23):7197-7211. PubMed ID: 37741939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognition.
    Aoki KR; Smith LA; Atassi MZ
    Crit Rev Immunol; 2010; 30(2):167-87. PubMed ID: 20370628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.
    White DM; Pellett S; Jensen MA; Tepp WH; Johnson EA; Arnason BG
    Infect Immun; 2011 Aug; 79(8):3388-96. PubMed ID: 21576339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin.
    Liu XY; Wei DK; Li ZY; Lu JS; Xie XM; Yu YZ; Pang XB
    Vaccine; 2023 Nov; 41(46):6834-6841. PubMed ID: 37816654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D.
    Gil LA; da Cunha CE; Moreira GM; Salvarani FM; Assis RA; Lobato FC; Mendonça M; Dellagostin OA; Conceição FR
    PLoS One; 2013; 8(7):e69692. PubMed ID: 23936080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A.
    Atassi MZ; Dolimbek BZ
    Protein J; 2004 Jan; 23(1):39-52. PubMed ID: 15115181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B.
    Jiang Y; Wang R; Guo J; Cheng K; Chen L; Wang X; Li Y; Du P; Gao C; Lu J; Yu Y; Yang Z
    Front Immunol; 2024; 15():1380694. PubMed ID: 38779676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.